The role of S-1 in the treatment of gastric cancer. - Wikidata - wikimedia - TriplyDB

The role of S-1 in the treatment of gastric cancer.

The role of S-1 in the treatment of gastric cancer.

http://www.wikidata.org/entity/Q37117556

about

Taxanes in the Treatment of Advanced Gastric Cancer Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.Cystoid macular edema associated with oral antineoplastic agent s-1 in a patient with diabetic retinopathy.S-1 and the treatment of gastric cancer with peritoneal dissemination Development and validation of a HPLC-MS/MS method with electrospray ionization for quantitation of potassium oxonate in human plasma: Application to a pharmacokinetic study.Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.S-1-based combination therapy vs S-1 monotherapy in advanced gastric cancer: a meta-analysis.Chemotherapy in the treatment of metastatic gastric cancer: is there a global standard?A comprehensive review of S-1 in the treatment of advanced gastric adenocarcinoma.Metastatic gastric cancer treatment: a little slow but worthy progress.Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer.Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.

P2860

Q26747708-701E77E9-EF4B-459F-BA7A-D90CD042F0A2 Q35068015-60E79927-093C-4DC7-92EC-3DC36BC78546 Q35920858-AAD03B3E-88B7-4121-8D93-6D88941313EA Q36230595-944E5D52-5B34-45F3-AB41-0FDFCFDE0232 Q36603976-4079A13D-FA96-4179-A6A7-9D00D149B114 Q37198610-B58745A1-442E-474D-B379-2DB3D67EF5E2 Q37454538-7F01C603-9538-4832-9F2F-974337A20806 Q37832986-9719A011-9D41-497E-8ADC-005CAF3536E6 Q37889959-E0C836BF-E709-42B2-937F-FE6542BA5808 Q38075499-A21B754E-6801-4032-87CA-38784423F626 Q38471350-966025DD-E565-40ED-92FC-B106D14F2361 Q38817753-D58F638F-1A6F-40B4-B211-7CC5F200AF15 Q39544715-326E558A-791D-49C4-9ABD-456733B1F350

P2860

The role of S-1 in the treatment of gastric cancer.

http://www.wikidata.org/entity/Q37117556

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The role of S-1 in the treatment of gastric cancer.

@en

The role of S-1 in the treatment of gastric cancer.

@nl

type

label

The role of S-1 in the treatment of gastric cancer.

@en

The role of S-1 in the treatment of gastric cancer.

@nl

prefLabel

The role of S-1 in the treatment of gastric cancer.

@en

The role of S-1 in the treatment of gastric cancer.

@nl

P1433

Q37117556-2E3034BF-9F07-4537-9417-41709863841B

P1476

Q37117556-58CE6D52-ED03-4BA6-A595-FC31E3D42400

P2093

Q37117556-15ECA89D-E18B-444F-AB11-58562ADA7830

P2860

Q37117556-0BC1ED7D-9644-49AD-8740-14FD250D2D2A

Q37117556-44272EB1-CE6C-4311-A98D-1DF19C4BB3F9

Q37117556-47AC9F0C-B052-4579-BC45-A0E25031BDC4

Q37117556-6522EDD9-9162-487B-93AA-03FD89B384FC

Q37117556-7B6F2B65-54A5-4E2C-AB4D-BD98E88F6A23

Q37117556-96F1CEDB-B042-42FB-8941-988E1E4A4510

Q37117556-C409E5C4-F978-44CE-B7E5-DD0FCDC1B356

Q37117556-EA3A3EAD-D469-49FB-9CD4-93BA463C6289

Q37117556-F07BDAC5-1015-433D-92C3-A476D2F63434

P2888

Q37117556-C99C287F-AC0F-424C-A70A-6ED9FEBA2FB2

P304

Q37117556-B2D23FFC-A605-4A80-9E04-B855E0CB5DCC

P31

Q37117556-368D5F47-86BB-4514-8801-932BFDC1B4CC

Q37117556-856ECDFD-BC19-4E4E-86F5-081A713754A6

P356

Q37117556-9DC6E32B-FF95-42B4-9D55-3F001F074820

P407

Q37117556-22030A19-724E-44FA-BF55-BFA69118E952

P433

Q37117556-2FF6A63B-6577-49D4-9B67-D3D773747E0B

P478

Q37117556-820B6A8C-0190-4CAA-965C-0EFFD6FCC685

P577

Q37117556-34260CEF-A067-4D67-970B-C434BCC02104

Q37117556-8935E8ED-3400-4F06-81BB-919F1C095E3C

P5875

Q37117556-CC6229CD-DD92-4E1D-9839-4BC875D3A2CC

P6179

Q37117556-C08AB34C-0579-41E4-9EEB-8518B58C9EE0

P698

Q37117556-49EB08AE-C730-4073-8975-4F49F76A639A

P921

Q37117556-024BDCCF-4222-4665-8C63-36AC3C371DFE

Q37117556-8D186541-C1A7-47BE-92C7-A1C55449C056

Q37117556-ED08DBA1-D1A8-445D-BF3B-A6616E8EADFC

P932

Q37117556-0BED984C-E575-4852-9BAE-E56C5E3546D0

P356

P1433

British Journal of Cancer

P1476

The role of S-1 in the treatment of gastric cancer.

@en

P2093

T Kubota

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Proton therapy in clinical practice: current clinical evidence.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer.

Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.

Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.

Phase I and pharmacokinetic study of the oral fluoropyrimidine S-1 on a once-daily-for-28-day schedule in patients with advanced malignancies.

Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer.

P2888

P304

1301-1304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604332

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2008-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5489329

http://www.w3.org/2001/XMLSchema#string

P6179

1014830584

http://www.w3.org/2001/XMLSchema#string

P698

18362933

http://www.w3.org/2001/XMLSchema#string

P921

stomach neoplasm

mechanism of action

P932

2361710

http://www.w3.org/2001/XMLSchema#string